189 Treatment of chronic hepatitis C with peginterferon ALFA-2A (40KD) (PEGASYS®) and ribavirin (COPEGUS®): patient age has a marked influence on the individual estimated probability of achieving a sustained virological response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

189 Treatment of chronic hepatitis C with peginterferon ALFA-2A (40KD) (PEGASYS®) and ribavirin (COPEGUS®): patient age has a marked influence on the individual estimated probability of achieving a sustained virological response

Published:2003 Issue: Volume:38 Page:246-246
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

FOSTER G,FRIED M,HADZIYANNIS S,CHANEAC M

Publisher

Elsevier BV

Subject

Hepatology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network;Hepatitis Monthly;2014-05-25

2. Risk score based PEG Interferon alpha 2b and Ribavirin treatment response estimation model for genotype 1 chronic hepatitis C patients;Advances in Medical Sciences;2011-12

3. Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study;Epidemiology and Infection;2011-11-29

4. Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment;Journal of Viral Hepatitis;2010-05

5. Current Approaches to HCV Infection in Current and Former Injection Drug Users;Journal of Addictive Diseases;2008-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP